Literature DB >> 714590

Usher syndrome in four hard-of-hearing siblings.

S L Davenport, S O'Nuallain, G S Omenn, R J Wilkus.   

Abstract

Retinitis pigmentosa (RP) and congenital deafness comprise the autosomal recessive Usher syndrome. The four affected siblings discussed here have audiometric curves characteristic of the 10% of patients with the syndrome who are not profoundly deaf. The oldest already has RP. Even though the younger three siblings have no visual symptoms, they do have auditory signs of the syndrome; they almost certainly will develop RP and become deaf-blind adults. Electroretinography indicates that the second oldest boy has early evidence of rod dysfunction. Special audiometric tests and electronystagmographic results support previous reports of a peripheral rather than central auditory lesion. The heterozygote parents show unilateral high-frequency hearing losses with normal retinal and vestibular function.

Entities:  

Mesh:

Year:  1978        PMID: 714590

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Ush1c gene expression levels in the ear and eye suggest different roles for Ush1c in neurosensory organs in a new Ush1c knockout mouse.

Authors:  Cong Tian; Xue Z Liu; Fengchan Han; Heping Yu; Chantal Longo-Guess; Bin Yang; Changjun Lu; Denise Yan; Qing Y Zheng
Journal:  Brain Res       Date:  2010-03-06       Impact factor: 3.252

2.  Usher's syndrome.

Authors:  R A Pagon
Journal:  Br J Ophthalmol       Date:  1980-02       Impact factor: 4.638

3.  A genetic analysis of retinitis pigmentosa.

Authors:  J A Boughman; G A Fishman
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

4.  Retinitis pigmentosa and the question of photoreceptor connecting cilium defects.

Authors:  P J Szczesny
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-05       Impact factor: 3.117

5.  Retinitis pigmentosa and deafness.

Authors:  R P Mills; D M Calver
Journal:  J R Soc Med       Date:  1987-01       Impact factor: 18.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.